![]() |
市場調查報告書
商品編碼
2021509
個人化營養保健品混合市場預測至2034年-按產品類型、成分、原料、訂閱模式、應用、最終用戶和地區分類的全球分析Personalized Nutraceutical Blends Market Forecasts to 2034 - Global Analysis By Product Type, Component, Raw Material, Subscription Model, Application, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,全球個人化營養保健品混合物市場預計將在 2026 年達到 84 億美元,並在預測期內以 13.2% 的複合年成長率成長,到 2034 年達到 226 億美元。
個人化營養保健品是指根據個別健康評估結果(包括基因檢測、生物標記分析、飲食調查和人工智慧健康演算法)量身定做的配方,其中包含維生素、礦物質、植物萃取物、益生菌、蛋白質和功能性生物活性化合物。其目的是解決不同年齡層和生活方式人群的特定營養缺乏問題、實現健康目標並改善健康狀況。
基於DNA的營養需求
對基於DNA的營養產品的需求正在加速個人化營養保健品的普及。這是因為價格親民的D2C(直接面對消費者)基因檢測使消費者能夠在分子層面上識別營養代謝變異、營養缺乏傾向和補充劑需求。將基因組數據與人工智慧驅動的配方引擎相結合的公司正在吸引那些願意為經過科學檢驗的個人化補充劑方案支付更高價格的健康意識消費者,從而推動D2C訂閱平台的收入成長。
高昂的配方成本
高昂的配方和生產成本限制了個人化營養保健品在價格敏感型消費者中的市場滲透率。這是因為客製化生產需要專門的原料採購、小批量生產設施和先進的品管系統,與大規模生產的保健品相比,這些都會顯著增加單位成本。高昂的價格使得個人化營養保健品超出了全球大多數潛在消費者的負擔範圍。
融入企業健康體系
將產品整合到企業健康計畫中蘊藏著大規模的分銷機會。這是因為雇主贊助的健康計畫擴大將個人化營養補充品納入其中,以降低醫療成本、提高員工生產力並改善員工健康。與企業健康管理機構簽訂的多員工契約,使訂閱平台提供者能夠獲得大規模的經常性收入,同時透過與企業管道的夥伴關係降低單一客戶的獲客成本。
監理合規風險
監管合規的複雜性威脅著個人化膳食補充劑混合市場的成長。國際膳食補充劑法規繁多,涵蓋健康益處聲明、新成分核准和定製配方標準等各個方面,這些法規不僅構成市場准入壁壘,也帶來了沉重的合規成本。隨著美國食品藥物管理局 (FDA) 和歐洲食品安全局 (EFSA) 對人工智慧產生的健康建議和個人化補充劑功效聲明的監管力度不斷加大,企業可能需要投入大量資金進行臨床驗證,這將使新興平台營運商處於不利地位。
新冠疫情加速了個人化營養保健品的普及,疫情期間人們對免疫力的關注度提高,刺激了消費者對用於維持免疫功能的標靶補充劑的需求。遠距健康檢查平台和遠端保健的整合,也使得人們能夠更方便地獲得個人化營養服務。在後疫情時代,人們對健康問題的持續關注和對預防性保健的投入,從根本上提高了對循證個性化營養保健品的需求,其認知水平遠超疫情初期。
在預測期內,ω-3 和必需脂肪酸混合物細分市場預計將成為最大的細分市場。
預計在預測期內,Omega 和必需脂肪酸混合物細分市場將佔據最大的市場佔有率。這主要歸功於已確立的臨床證據,這些證據支持Omega-3補充劑對心血管、認知功能和抗發炎等方面的健康益處,從而持續帶動各年齡層消費者的高需求。醫生經常推薦 Omega 補充劑,以及消費者因魚貝類消費量下降而日益關注膳食中 EPA 和 DHA 的缺乏,共同促成了該細分市場在個性化混合產品類型中的主導地位。
預計在預測期內,硬體領域將呈現最高的複合年成長率。
在預測期內,硬體領域預計將呈現最高的成長率。這主要得益於家用生物標記檢測設備、自動化營養補充劑分發系統以及穿戴式健康監測設備的日益普及,這些設備能夠基於即時生理數據流,持續實現營養補充劑配方的個性化客製化。硬體驅動的健康感測平台與人工智慧驅動的營養補充品推薦平台的融合,正在打造一個全新的高價值產品類型,預計將受到注重科技的健康消費者的青睞,並有望以溢價購買。
在預測期內,北美預計將佔據最大的市場佔有率。這主要歸功於美國擁有全球最成熟的D2C(直接面對消費者)營養補充品產業,消費者願意為個人化健康產品支付高價,基因組檢測的普及率不斷提高,以及人工智慧營養平台開發商的主導地位。高人均健康相關自由裁量權支出、強大的數位健康基礎設施以及有利於營養補充劑創新的法規環境,都為北美在個人化營養保健品領域的銷售領先地位提供了有力支撐。
在預測期內,亞太地區預計將呈現最高的複合年成長率。這主要歸功於中國、印度、日本和韓國健康意識日益增強的中產階級人口的快速成長,以及他們對個性化健康習慣的採納、保健品電商管道的拓展,以及當地對營養基因組學研發和個性化營養平台建設的投入不斷增加。政府推行的健康促進項目,包括支持預防性營養和擴大遠端醫療基礎設施,使得該地區的消費者更容易獲得個人化營養保健品訂閱服務。
主要進展
2026 年 3 月,Hims & Hers Health 宣布與一家基因組學公司建立策略合作夥伴關係,將基於 DNA 的營養代謝分析整合到其個人化健康和營養保健品訂閱服務中。
2026 年 2 月,Viome Life Sciences 將其基於腸道微生物組的精準營養服務擴展到歐洲市場,透過其專有的 RNA定序技術,能夠推薦個人化的益生菌和益生元混合物。
2026 年 1 月,Thorne Research推出了一款由人工智慧驅動的個人化補充劑平台,該平台將生物標記血液測試與客製化的每月營養保健品包處方相結合,並開始向 D2C(直接面對消費者)健康訂閱用戶提供該平台。
According to Stratistics MRC, the Global Personalized Nutraceutical Blends Market is accounted for $8.4 billion in 2026 and is expected to reach $22.6 billion by 2034 growing at a CAGR of 13.2% during the forecast period. Personalized nutraceutical blends refer to customized formulations of vitamins, minerals, botanical extracts, probiotics, proteins, and functional bioactive compounds assembled according to individualized health assessments derived from genetic testing, biomarker analysis, dietary surveys, and AI-driven health algorithms to address specific nutritional gaps, health goals, and wellness conditions of individual consumers across diverse age groups and lifestyle profiles.
DNA-Based Nutrition Demand
DNA-based nutrition demand is accelerating personalized nutraceutical blend adoption as affordable direct-to-consumer genetic testing enables consumers to identify nutrient metabolism variants, deficiency predispositions, and supplementation needs at the molecular level. Companies integrating genomic data with AI-driven formulation engines are attracting health-conscious consumers willing to pay premium prices for scientifically validated personalized supplement protocols, driving revenue expansion across direct-to-consumer subscription platforms.
High Formulation Costs
High formulation and manufacturing costs constrain personalized nutraceutical blend market penetration among price-sensitive consumer segments as customized production requires specialized ingredient sourcing, small-batch manufacturing infrastructure, and sophisticated quality control systems that substantially elevate per-unit production expenses relative to mass-market supplement alternatives. Premium pricing positions personalized blends beyond affordability thresholds for large portions of the potential global consumer population.
Corporate Wellness Integration
Corporate wellness program integration represents a high-volume distribution opportunity as employer-sponsored health programs adopt personalized nutraceutical supplementation to reduce healthcare costs, improve employee productivity, and enhance workforce wellness outcomes. Multi-employee contract arrangements with corporate wellness administrators enable subscription platform operators to secure large recurring revenue pools while reducing individual customer acquisition costs through institutional channel partnerships.
Regulatory Compliance Risks
Regulatory compliance complexity threatens personalized nutraceutical blend market expansion as varying international supplement regulations governing health claims, novel ingredient approvals, and customized formulation standards create market entry barriers and compliance cost burdens. Evolving FDA and EFSA scrutiny of AI-generated health recommendations and personalized supplement claims may require extensive clinical substantiation investments that disadvantage emerging platform operators.
COVID-19 accelerated personalized nutraceutical adoption as pandemic-era immunity consciousness elevated consumer interest in targeted supplementation for immune resilience. Remote health assessment platforms and telehealth integrations expanded digital access to personalized nutrition services. Post-pandemic sustained health engagement and preventive wellness investment have structurally elevated demand for science-backed personalized nutraceutical formulations beyond initial pandemic-driven awareness levels.
The omega & essential fatty acid blends segment is expected to be the largest during the forecast period
The omega & essential fatty acid blends segment is expected to account for the largest market share during the forecast period, due to well-established clinical evidence supporting omega-3 supplementation for cardiovascular, cognitive, and anti-inflammatory health benefits that drives consistent high-volume consumer demand across all demographic segments. Physician recommendation frequency for omega supplementation combined with growing consumer awareness of dietary EPA and DHA deficiencies from declining seafood consumption sustains this segment's dominant market position among personalized blend product categories.
The hardware segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the hardware segment is predicted to witness the highest growth rate, driven by expanding deployment of at-home biomarker testing devices, automated nutraceutical dispensing systems, and wearable health monitoring equipment that enable continuous personalization of supplement formulations based on real-time physiological data streams. Integration of hardware-enabled health sensing with AI-driven supplement recommendation platforms is creating new high-value product categories that command premium pricing from technology-oriented wellness consumers.
During the forecast period, the North America region is expected to hold the largest market share, due to the United States hosting the world's most mature direct-to-consumer supplement industry with established consumer willingness to pay premium prices for personalized health products, strong genomic testing adoption, and leading AI nutrition platform developers. High household discretionary health spending, robust digital health infrastructure, and favorable regulatory environments for dietary supplement innovation sustain North American revenue leadership across personalized nutraceutical categories.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to rapidly growing health-conscious middle-class populations in China, India, Japan, and South Korea adopting personalized wellness practices, expanding e-commerce supplement distribution, and increasing local investment in nutrigenomics research and personalized nutrition platform development. Government health promotion programs supporting preventive nutrition and growing telehealth infrastructure are accelerating regional consumer access to personalized nutraceutical subscription services.
Key players in the market
Some of the key players in Personalized Nutraceutical Blends Market include Care/of (Ritual), Persona Nutrition, Rootine, Baze, Nourished, Hims & Hers Health, Thorne Research, Metagenics, USANA Health Sciences, Amway (Nutrilite), Herbalife Nutrition, Nature's Sunshine Products, Gaia Herbs, New Chapter, Garden of Life, Pure Encapsulations, and Viome Life Sciences.
Key Developments
In March 2026, Hims & Hers Health announced a strategic partnership with a genomics company to integrate DNA-based nutrient metabolism profiling into its personalized wellness and nutraceutical subscription offerings.
In February 2026, Viome Life Sciences expanded its gut microbiome-based precision nutrition service to European markets, enabling personalized probiotic and prebiotic blend recommendations through proprietary RNA sequencing technology
In January 2026, Thorne Research launched an AI-powered personalized supplement platform integrating biomarker blood testing with customized monthly nutraceutical pack formulation for direct-to-consumer wellness subscribers.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.